CAS: 1414943-88-6
![1,3,5-Triazin-2-amine, 4-(4-fluoro-2-methoxyphenyl)-N-[3-[(S-methylsulfonimidoyl)methyl]phenyl]-](https://static.cymitquimica.com/products/IN/thumb/DA001GHG.jpg)
1,3,5-Triazin-2-amine, 4-(4-fluoro-2-methoxyphenyl)-N-[3-[(S-methylsulfonimidoyl)methyl]phenyl]-
CAS:1414943-88-6
Formula:
C18H18FN5O2S
Purity:
98%
Molecular weight:
387.4312
Ref: IN-DA001GHG
| 5mg | 125.00 € | ||
| 10mg | 197.00 € | ||
| 25mg | 239.00 € | ||
| 50mg | 538.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Atuveciclib Racemate
CAS:1414943-88-6
Atuveciclib Racemate is an oral CDK9 inhibitor with a 13 nM IC50, targeting P-TEFb/CDK9 selectively.
Formula:
C18H18FN5O2S
Purity:
97.29%
Color and Shape:
Solid
Molecular weight:
387.43
Ref: TM-T10464L
| 1mg | 89.00 € | ||
| 2mg | 120.00 € | ||
| 5mg | 201.00 € | ||
| 10mg | 328.00 € | ||
| 25mg | 609.00 € | ||
| 50mg | 810.00 € | ||
| 100mg | 1,113.00 € | ||
| 1mL*10mM (DMSO) | 222.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
Atuveciclib (BAY-1143572)
CAS:1414943-88-6
Atuveciclib is a selective inhibitor of CDK4 and CDK6 that has been shown to inhibit …
Formula:
C18H18FN5O2S
Purity:
Min. 95%
Molecular weight:
387.43 g/mol
Ref: 3D-PGC94388
| 5mg | 636.00 € | ||
| 10mg | 969.00 € | ||
| 25mg | 1,710.00 € | ||
| 50mg | 2,736.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
